These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The use of monoclonal antibodies for the identification and classification of acute myeloid leukemias. Drexler HG; Minowada J Leuk Res; 1986; 10(3):279-90. PubMed ID: 3512924 [TBL] [Abstract][Full Text] [Related]
47. Myeloid lineage specificity and high sensitivity of monoclonal antibody GM 58/8 proves its usefulness as a diagnostic reagent in acute leukemia. Das Gupta A; Dhond SR; Barbhaya SA; Advani SH Am J Hematol; 1987 Jun; 25(2):125-30. PubMed ID: 3300282 [TBL] [Abstract][Full Text] [Related]
48. Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2. Drexler HG; Sagawa K; Menon M; Minowada J Leuk Res; 1986; 10(1):17-23. PubMed ID: 3456072 [TBL] [Abstract][Full Text] [Related]
49. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones. Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497 [TBL] [Abstract][Full Text] [Related]
50. Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia. Caron PC; Lai LT; Scheinberg DA Clin Cancer Res; 1995 Jan; 1(1):63-70. PubMed ID: 9815888 [TBL] [Abstract][Full Text] [Related]
51. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia]. Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276 [TBL] [Abstract][Full Text] [Related]
52. Immunophenotype of clonogenic cells in myeloid leukaemia. Kabral A; Bradstock KF; Grimsley P; Favaloro EJ Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752 [TBL] [Abstract][Full Text] [Related]
53. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia. Caron PC; Dumont L; Scheinberg DA Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458 [TBL] [Abstract][Full Text] [Related]
54. [Study of leukemic colony-forming units (CFU-L) in non-lymphoblastic malignant hemopathies]. Almeida J; Cañizo C; Sánchez IJ; Nieto MJ; San Miguel JF; González M; Orfao A Sangre (Barc); 1989 Dec; 34(6):467-70. PubMed ID: 2629122 [TBL] [Abstract][Full Text] [Related]
55. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032 [TBL] [Abstract][Full Text] [Related]
56. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis]. Baryshnikov AIu Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771 [TBL] [Abstract][Full Text] [Related]
57. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis. Drexler HG; Menon M; Gaedicke G; Minowada J Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629 [TBL] [Abstract][Full Text] [Related]
58. Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences. Kersemans V; Cornelissen B; Minden MD; Brandwein J; Reilly RM J Nucl Med; 2008 Sep; 49(9):1546-54. PubMed ID: 18703602 [TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia. Schwarzinger I; Valent P; Köller U; Marosi C; Schneider B; Haas O; Knapp W; Lechner K; Bettelheim P J Clin Oncol; 1990 Mar; 8(3):423-30. PubMed ID: 2307987 [TBL] [Abstract][Full Text] [Related]